Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers

NCT07747896 — Not applicable, Recruiting, 80 participants, Nordsjaellands Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers; a Randomized Clinically Controlled Trial

RegistryNCT07747896, acronym TSS
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment80 (Estimated)
SponsorNordsjaellands Hospital (Other); collaborators: Frederikssund Municipality, Denmark
ConditionsDiabetic Foot Disease, Diabetic Foot Infection, Diabetic Foot Ulcer (DFU), Ulcer, Hard to Heal Wounds
Interventionscoordinated primary-care-based MDT-model, Standard Care (in control arm) (Other)
Datesstart 2026-08-01 (estimated), primary completion 2027-04-30 (estimated), completion 2028-10-31 (estimated), first posted 2026-08-05, last updated 2026-08-05
Locations1 site in Denmark

Related Papers Related Patents Related Grants Related Experts
All trials for Diabetic Foot Disease All trials for Diabetic Foot Infection All trials of coordinated primary-care-based MDT-model All trials of Standard Care (in control arm)

-Summary

The TSS project is a study of the effects of treating hard-to-heal ulcers in a multidisciplinary cross sectional team, meaning that nurse and doctor from a hospital based wound healing clinic and wound care nurse from the primary care sector treat the patient in collaboration rather than the current form where care in municipalities and hospital setting, communicate but treat the patient on their own. The study is designed as a randomized study, meaning that individuals with hard-to-heal ulcers are randomly designated to standard care or the multidis-ciplinary team. We measure several aspects of the new format, but the main outcome com-pared between the two groups (standard care and multidisciplinary care) is number of ulcers healed.

Participants are followed for a year after inclusion in the study, and have 6 fixed visits in the clinic, with the possibility of more visits if necessary.

There is no "new" medicine, surgery or other treatments planned in the study, but the multi-disciplinary team can offer and implement any treatment deemed appropriate for the individ-ual that is allocated to the multidisciplinary team, of course the individual has the opportunity to decline any treatment offered by the team. The control group, i.e. individuals allocated to standard care, will receive the treatment that is normally available to individuals with hard-to-heal ulcers treated in the municipality, including referral to hospital based treatments.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
coordinated primary-care-based MDT-modelExperimentalOther: coordinated primary-care-based MDT-modelThe proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing, the participant is pla
Standard CareActive comparatorOther: Standard Care (in control arm)Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.
  • coordinated primary-care-based MDT-model (Other): The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following
  • Standard Care (in control arm) (Other): Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.

+Outcome measures

Primary outcomes

  • Ulcer healing [Ulcer healing at 12 months]: Number of individuals that achieve healing of their hard-to-heal ulcer(s), compared between two arms

Secondary outcomes

  • Time to ulcer healing [12 moths]: Mean time (in days) to healing of healed hard-to-heal ulcer(s) in days - compared between groups
  • Ulcer recurrence [12 months]: Incidence of recurrence of ulcer following healing of hard-to-heal ulcer(s) - compared between groups
  • Infections [12 months]: Incidence of infections divided in * Infection treated with tablet antibiotic * Infection treated with intravenous antibiotics, admittance to hospital and/or surgery Compared between groups
  • Amputations [12 months]: Incidence and amputations in total and divided in * Below ankle amputation * Above ankle amputations Compared between groups
  • Visits [12 months]: Number of visits to clinics due to hard-to-heal ulcer(s) - compared between groups
  • Hospital admissions [12 months]: Days admitted to hospital due to hard-to-heal ulcer(s) - compared between groups
  • Patient related outcomes [12 months]: Patient related outcomes (Wound-QoL) - compared between groups Wound-Qol is a PROM tool designed for patients living with chronic ulcers, and is scored on 17-items, from 0 to 4 for each item. The higher the score the worse the outcome. The scores are registered as a global score for all 17 items and divided in three subscales.
  • Cost effectiveness [12 months]: Cost effectiveness of intervention will be assessed by comparing expenditures between intervention and control group at four levels; 1. Hospital based care: Calculated using yearly Diagnosis Related Group (DRG) rates determined by the Danish Health Data Authority, obtained from the Danish National Patient Register 2. Primary care: Calculated using fees paid to healthcare providers by the health management regions, including general practitioners, podiatrists, and other specialists in primary care. 3. Prescribed medication: Calculated as the total cost of medication, including any out-of-pocket expenses, obtained from the Danish National Prescription Registry 4. Municipal home care: Calculated based on the average number of minutes of home care provided weekly, summed to total monthly hours. These hours are multiplied by the average hourly cost found in the national database of municipal services Were cost are not directly discernable from the above mentioned data sources estimates of
  • RE-AIM [12 months]: RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (first given here) o Reach will be assessed using data available from Frederikssund Kommune on number of individuals with hard-to-heal ulcer(s) treated that can be reached with the cross-sectional MDT intervention in the municipality.
  • RE-AIM [12 months]: RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (second given here) o Effect will be assessed by the clinical outcomes described above i.e., ulcer healing, infection etc.
  • RE-AIM [12 months]: RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (third given here) o Adoption will be assessed on a local (NOHs catchment area), regional (the Capital Region of Denmark) and on a Danish level, by the number of clinics that have adopted the cross-sectional MDT model.
  • RE-AIM [12 months]: RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (fourth given here) o Implementation will be assessed by the proportion of eligible individuals with hard-to-heal-ulcers offered the MDT-approach in Frederikssund Kommune.
  • RE-AIM [12 months]: RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (fifth given here) o Maintenance will be assessed by how many of the clinics that have adopted the intervention actually maintain the intervention over time.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients aged 18 years or above
* Hard-to-heal ulcer(s)
* Able to understand written and oral information
* Ability to follow planned visits and treatment
* Able to provide informed consent in Danish and/or English

Exclusion Criteria:

Revascularization procedure in the affected limb planned, or undertaken within the 4 weeks prior to screening

* Toe blood pressure < 35mmHg
* Infections of the ulcer needing acute or sub-acute (defined as within seven days) surgical treatment
* Prior major amputations on affected or contralateral leg
* Current treatment with cytotoxic drugs or with systemically administered glucocorticoids
* Likely inability to comply with the need for planned visits because of planned activities
* Participation in another interventional ulcer-healing trial within the 4 weeks prior to screening
* Prior enrolment in this trial
* Judgement by the investigator that the patient does not have the capacity to understand the study procedures or provide written informed consent

+Locations (1)

FacilityCityCountryStatus
North Zealand HospitalHillerødDenmarkRecruiting

+Study documents